BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
Most tumours associated with germline BRCA1/BRCA2 loss of function mutations respond to DNA damaging agents, however, some do not. Herein, the authors identify that a subset of breast/ovarian tumors retain a normal allele, which is associated with decreased overall survival after DNA damage-inducing...
Guardado en:
Autores principales: | Kara N. Maxwell, Bradley Wubbenhorst, Brandon M. Wenz, Daniel De Sloover, John Pluta, Lyndsey Emery, Amanda Barrett, Adam A. Kraya, Ioannis N. Anastopoulos, Shun Yu, Yuchao Jiang, Hao Chen, Nancy R. Zhang, Nicole Hackman, Kurt D’Andrea, Robert Daber, Jennifer J. D. Morrissette, Nandita Mitra, Michael Feldman, Susan M. Domchek, Katherine L. Nathanson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f6f94b247c0462089e5fb392de747ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
por: D. Torres, et al.
Publicado: (2017) -
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
por: Miyuki Kitahara, et al.
Publicado: (2021) -
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Hikmat Abdel-Razeq, et al.
Publicado: (2021) -
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
por: Gaik Theng Toh, et al.
Publicado: (2008) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021)